Literature DB >> 18331237

Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy.

Steven F Solga1, Alena Horska, Susanne Hemker, Stephen Crawford, Charalett Diggs, Anna Mae Diehl, Frederick L Brancati, Jeanne M Clark.   

Abstract

BACKGROUND/AIMS: Magnetic resonance spectroscopy (MRS) measures hepatic fat and adenosine triphosphate (ATP), but magnetic resonance studies are challenging in obese subjects. We aimed to evaluate the inter- and intrarater reliability and stability of hepatic fat and ATP measurements in a cohort of overweight and obese adults.
METHODS: We measured hepatic fat and ATP using proton MRS ((1)H MRS) and phosphorus MRS ((31)P MRS) at baseline in adults enrolled in the Action for Health in Diabetes (Look AHEAD) clinical trial at one site. Using logistic regression, we determined factors associated with successful MRS data acquisition. We calculated the intra- and inter-rater reliability for hepatic fat and ATP based on 20 scans analysed twice by two readers. We also calculated the stability of these measures three times on five healthy volunteers.
RESULTS: Of 244 participants recruited into our ancillary study, 185 agreed to MRS. We obtained usable hepatic fat data from 151 (82%) and ATP data from 105 (58%). Obesity was the strongest predictor of failed data acquisition; every unit increase in the body mass index reduced the likelihood of successful fat data by 11% and ATP data by 14%. The inter- and intrarater reliability were excellent for fat (intraclass correlation coefficient=0.99), but substantially more variable for ATP. Fat measures appeared relatively stable, but this was less true for ATP.
CONCLUSIONS: Obesity can hinder (1)H and (31)P MRS data acquisition and subsequent analysis. This impact was greater for hepatic ATP than hepatic fat.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18331237      PMCID: PMC3096527          DOI: 10.1111/j.1478-3231.2008.01705.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  22 in total

1.  Single-voxel proton MRS of the human brain at 1.5T and 3.0T.

Authors:  P B Barker; D O Hearshen; M D Boska
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

Review 2.  [3 Tesla MRI: successful results with higher field strengths].

Authors:  F Schmitt; D Grosu; C Mohr; D Purdy; K Salem; K T Scott; B Stoeckel
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

3.  Current and future applications of in vitro magnetic resonance spectroscopy in hepatobiliary disease.

Authors:  I Jane Cox; Amar Sharif; Jeremy F L Cobbold; Howard C Thomas; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 4.  Spatial localization in NMR spectroscopy in vivo.

Authors:  P A Bottomley
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

5.  Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study.

Authors:  H Cortez-Pinto; J Chatham; V P Chacko; C Arnold; A Rashid; A M Diehl
Journal:  JAMA       Date:  1999-11-03       Impact factor: 56.272

6.  Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  D V Mann; W W M Lam; N Magnus Hjelm; N M C So; D K W Yeung; C Metreweli; W Y Lau
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

7.  Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals.

Authors:  Satheesh Nair; Vadappuram P Chacko; Cheryl Arnold; Anna Mae Diehl
Journal:  Am J Gastroenterol       Date:  2003-02       Impact factor: 10.864

Review 8.  Measuring in-vivo metabolism using nuclear magnetic resonance.

Authors:  Robert L Dobbins; Craig R Malloy
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2003-09       Impact factor: 4.294

9.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

10.  Evidence for altered hepatic gluconeogenesis in patients with cirrhosis using in vivo 31-phosphorus magnetic resonance spectroscopy.

Authors:  K K Changani; R Jalan; I J Cox; M Ala-Korpela; K Bhakoo; S D Taylor-Robinson; J D Bell
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

View more
  6 in total

Review 1.  Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer.

Authors:  Pieter C Dagnelie; Susanne Leij-Halfwerk
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Hepatic energy state is regulated by glucagon receptor signaling in mice.

Authors:  Eric D Berglund; Robert S Lee-Young; Daniel G Lustig; Sara E Lynes; E Patrick Donahue; Raul C Camacho; M Elizabeth Meredith; Mark A Magnuson; Maureen J Charron; David H Wasserman
Journal:  J Clin Invest       Date:  2009-08       Impact factor: 14.808

3.  Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes.

Authors:  Manal F Abdelmalek; Mariana Lazo; Alena Horska; Susanne Bonekamp; Edward W Lipkin; Ashok Balasubramanyam; John P Bantle; Richard J Johnson; Anna Mae Diehl; Jeanne M Clark
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

4.  Quantitative study of liver magnetic resonance spectroscopy quality at 3T using body and phased array coils with physical analysis and clinical evaluation.

Authors:  Li Xu; Shiyong Gu; Qianjin Feng; Changhong Liang; Sherman Xuegang Xin
Journal:  PLoS One       Date:  2015-04-16       Impact factor: 3.240

Review 5.  In-vivo31P-MRS of skeletal muscle and liver: A way for non-invasive assessment of their metabolism.

Authors:  Ladislav Valkovič; Marek Chmelík; Martin Krššák
Journal:  Anal Biochem       Date:  2017-01-21       Impact factor: 3.365

6.  Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

Authors:  Giovanni Tarantino; Patrizia Colicchio; Paolo Conca; Carmine Finelli; Matteo Nicola Dario Di Minno; Marianna Tarantino; Domenico Capone; Fabrizio Pasanisi
Journal:  J Inflamm (Lond)       Date:  2009-03-16       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.